We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

48 hedge funds and large institutions have $253M invested in Cyteir Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 2

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

26% more funds holding

Funds holding: 38 → 48 (+10)

26% less capital invested

Capital invested by funds: $344M → $253M (-$90.7M)

Holders
48
Holders Change
+10
Holders Change %
+26.32%
% of All Funds
0.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
12
Increased
16
Reduced
9
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$2.53M
2
BlackRock
BlackRock
New York
+$2.3M
3
Morgan Stanley
Morgan Stanley
New York
+$1.28M
4
Millennium Management
Millennium Management
New York
+$790K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$660K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.61M
2
CCM
CAAS Capital Management
New York
-$1.56M
3
SI
Sofinnova Investments
California
-$1.02M
4
SFM
Sphera Funds Management
Israel
-$553K
5
Citadel Advisors
Citadel Advisors
Florida
-$482K
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$55M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$46M -$3.61M -236,666 -6%
RCM
3
RA Capital Management
Massachusetts
$38.1M – – –
OMC
4
OUP Management Company
Pennsylvania
$28.1M +$37.7M +2,474,572 New
APM
5
Avidity Partners Management
Texas
$21M +$2.53M +166,097 +10%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$20.6M -$88.4K -5,803 -0.3%
BBA
7
Baker Bros. Advisors
New York
$9.24M – – –
BlackRock
8
BlackRock
New York
$6.17M +$2.3M +151,023 +39%
CCM
9
CAAS Capital Management
New York
$5.43M -$1.56M -102,236 -18%
ACP
10
Acuta Capital Partners
California
$4.46M – – –
Vanguard Group
11
Vanguard Group
Pennsylvania
$3.9M +$30.2K +1,982 +0.6%
ABG
12
Ally Bridge Group
New York
$3.63M – – –
SI
13
Sofinnova Investments
California
$2.04M -$1.02M -66,871 -27%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$1.57M +$660K +43,281 +46%
State Street
15
State Street
Massachusetts
$1.3M +$349K +22,917 +25%
SFM
16
Sphera Funds Management
Israel
$1.12M -$553K -36,285 -27%
Morgan Stanley
17
Morgan Stanley
New York
$992K +$1.28M +84,002 +2,634%
Northern Trust
18
Northern Trust
Illinois
$823K -$11.6K -758 -1%
Millennium Management
19
Millennium Management
New York
$590K +$790K +51,860 New
UBS Group
20
UBS Group
Switzerland
$394K +$521K +34,192 +8,160%
Renaissance Technologies
21
Renaissance Technologies
New York
$298K +$399K +26,200 New
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$270K +$361K +23,713 New
Charles Schwab
23
Charles Schwab
California
$259K +$32.9K +2,158 +10%
GTCM
24
Gyon Technologies Capital Management
New Jersey
$254K +$341K +22,345 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$195K +$22.8K +1,499 +10%
1
2

CYT Hedge Fund Activity: Q4 2021 in Review

48 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q4 2021, worth a combined $253M — down 26% from $344M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CYT positions and 2 closed out — a net gain of 10 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was Avidity Partners Management, adding an estimated $2.53M. The largest seller was Fidelity Investments, cutting an estimated $3.61M.

  • 48 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q4 2021, up from 38 in Q3 2021.
  • Funds reported $253M of Cyteir Therapeutics, Inc. Common Stock stock for Q4 2021, down 26% quarter-over-quarter.
  • 12 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q4 2021 and 2 closed out, a net change of +10 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q4 2021 was Avidity Partners Management, an estimated $2.53M added.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q4 2021 was Fidelity Investments, an estimated $3.61M sold.

Based on aggregated 13F filings for Q4 2021.